down arrow

MAIA Biotechnology, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5526411021
USD
1.20
0.08 (7.14%)

Dec 04

ASE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.081.25

52 Week

0.872.74
Valuation
Technical
Day's Volume

CASH

651.63 k

Shareholding (Mar 2025)

FII

0.26%

Held by 4 FIIs

DII

96.22%

Held by 4 DIIs

Promoter

0.00%

How big is MAIA Biotechnology, Inc.?

22-Jun-2025

As of Jun 18, MAIA Biotechnology, Inc. has a market capitalization of 50.31 million and reported net sales of 0.00 million with a net profit of -19.71 million over the last four quarters.

Market Cap: As of Jun 18, MAIA Biotechnology, Inc. has a market capitalization of 50.31 million, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters, MAIA Biotechnology, Inc. reported net sales of 0.00 million and a net profit of -19.71 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 3.63 million and total assets of 10.16 million.

Read More

What does MAIA Biotechnology, Inc. do?

22-Jun-2025

MAIA Biotechnology, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $5 million and a market cap of $50.31 million. Key financial metrics include a negative P/E ratio, a debt equity ratio of -2.20, and a return on equity of -366.01%.

Overview: <BR>MAIA Biotechnology, Inc. operates within the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -5 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 50.31 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -2.20 <BR>Return on Equity: -366.01% <BR>Price to Book: 10.18<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is MAIA Biotechnology, Inc. technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, MAIA Biotechnology, Inc. has shifted to a mildly bearish trend, with mixed technical indicators and significant underperformance compared to the S&P 500, showing a year-to-date decline of 20.71% versus the S&P's gain of 12.22%.

As of 9 September 2025, the technical trend for MAIA Biotechnology, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD shows a mildly bullish signal on the weekly chart but is bearish on the monthly. The Bollinger Bands are bearish on the weekly and mildly bearish on the monthly, while moving averages indicate a bearish trend on the daily timeframe. The KST is bearish on the weekly, and Dow Theory shows no trend on the weekly but is mildly bearish on the monthly. The OBV is bullish on the monthly but shows no trend on the weekly.<BR><BR>In terms of performance, MAIA has underperformed significantly compared to the S&P 500 across all multi-period returns, with a year-to-date decline of 20.71% versus the S&P's gain of 12.22%, and a one-year decline of 43.93% compared to the S&P's 17.14% increase.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 52 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-2.62

stock-summary
Return on Equity

-501.71%

stock-summary
Price to Book

13.53

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-19.46%
0%
-19.46%
6 Months
-31.82%
0%
-31.82%
1 Year
-40.3%
0%
-40.3%
2 Years
33.33%
0%
33.33%
3 Years
-67.48%
0%
-67.48%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

MAIA Biotechnology, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is MAIA Biotechnology, Inc. technically bullish or bearish?

As of 9 September 2025, the technical trend for MAIA Biotechnology, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD shows a mildly bullish signal on the weekly chart but is bearish on the monthly. The Bollinger Bands are bearish on the weekly and mildly bearish on the monthly, while moving averages indicate a bearish trend on the daily timeframe. The KST is bearish on the weekly, and Dow Theory shows no trend on the weekly but is mildly bearish on the monthly. The OBV is bullish on the monthly but shows no trend on the weekly. In terms of performance, MAIA has underperformed significantly compared to the S&P 500 across all multi-period returns, with a year-to-date decline of 20.71% versus the S&P's gain of 12.22%, and a one-year decline of 43.93% compared to the S&P's 17.14% increase....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-27.49%
EBIT to Interest (avg)
-16.50
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.20
Sales to Capital Employed (avg)
0
Tax Ratio
0.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.10%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
11.04
EV to EBIT
-2.36
EV to EBITDA
-2.36
EV to Capital Employed
-7.38
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-366.01%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (3.52%)

Foreign Institutions

Held by 4 Foreign Institutions (0.26%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 40.45% vs -97.78% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.20",
          "val2": "-3.80",
          "chgp": "-36.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-5.20",
          "chgp": "94.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.30",
          "val2": "-8.90",
          "chgp": "40.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -17.68% vs -25.32% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-17.00",
          "val2": "-20.40",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.60",
          "val2": "0.40",
          "chgp": "-1,750.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-23.30",
          "val2": "-19.80",
          "chgp": "-17.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-5.20
-3.80
-36.84%
Interest
0.00
0.00
Exceptional Items
-0.30
-5.20
94.23%
Consolidate Net Profit
-5.30
-8.90
40.45%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 40.45% vs -97.78% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-17.00
-20.40
16.67%
Interest
0.00
0.00
Exceptional Items
-6.60
0.40
-1,750.00%
Consolidate Net Profit
-23.30
-19.80
-17.68%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -17.68% vs -25.32% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About MAIA Biotechnology, Inc. stock-summary
stock-summary
MAIA Biotechnology, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."